Effect and Mechanism of Microrna-126-3p on Inflammatory Response after Spinal Cord Injury in Rats
Guo Jia,Yang Min,Xie Yuanlong,Wei Renxiong
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.07.036
2018-01-01
Abstract:Objective To investigate the effect and mechanism of microRNA (miRNA,miR)-126-3p on inflammatory response after spinal cord injury in rats.Methods The SD rat model of spinal cord injury was established.The relative expression of miR-126 in the spinal cord tissues of 3,7 and 14 d after spinal cord injury in rats was detected by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR).The effect of agomir-126 injection on the motor function of rats with acute spinal cord injury was evaluated by Basso-Beattie-Bresnahan (BBB) scoring method,and the online target gene was used to predict the database Targetscan.The target gene of miR-126-3p was predicted and the target gene of agomir-126 was verified by double luciferase reporter gene.After transfecting NEURO-2A cells to 150 nmol/L concentration miR-126-3p mimics for 24 hours,Western blotting was used to detect the change of the expression level of interleukin (IL)-7 protein,and Western blotting was used to detect the agomir-126 administration group.In the negative control group (agomir-NC),the expression level of inflammation related factors in spinal cord injured rats was changed.Results The expression level of miR-126 in spinal cord tissue of model group (2.13 ±0.44) in 3 days was lower than that of control group (3.69 ±0.59,t =2.769,P =0.021).The expression level of miR-126 in spinal cord tissue of model group (1.85 ± 0.42) in 7 days was lower than that of control group (3.77 ± 0.88,t =2.485,P=0.026).The expression level of miR-126 in spinal cord tissue of model group (1.33 ± 0.28) in 14 days was lower than that of control group (3.82 ±0.92,t =3.388,P =0.019).The BBB score of 3 days in the agomir-126 group (4.690 ± 0.530) was higher than that of the control group (3.650 ±0.350,t =3.661,P =0.006);The BBB score of 7 days in the agomir-126 group was higher than that of the control group (3.690 ± 0.650,t =5.452,P =0.001),and agomir-126 administration group 14 days (6.720 ± 0.770) was higher than that of the control group (3.770 ± 0.470,t =7.320,P =0.001).The luciferase activity ratio of IL-7-WT-3'UTR and miR-126-3p mimic co-transfection group (6.92 ±0.556) was significantly lower than that of the control group (13.69 ±0.925,t =10.870,P =0.001).The expression of IL-7 protein in miR-126 mimic transfection group (0.23 ± 0.14) NEURO-2A cells was lower than that in the control group (0.86 ±0.17,t =4.955,P =0.009).The expression of IL-7 protein in the spinal cord of the drug group (0.369 ± 0.093) SCI rats was lower than that of the control group (0.956 ± 0.124,t =6.559,P =0.003),and the expression of IL-1 beta protein in the spinal cord of the administration group (0.572 ± 0.085) SCI rats was lower than that of the control group (0.764 ±0.086,t =2.750,P=0.026),and the spinal cord of the drug group (0.133 ± 0.009) SCI rat ridges The expression of TGF-beta protein was lower than that in the control group (0.257±0.028,t=7.303,P=0.002).Conclusion The expression of miR-126-3p in spinal cord injury is reduced,and up regulation of miR-126-3p can protect the spinal cord injury.The mechanism may be related to the inflammatory response of the spinal cord injury mediated by the key target gene IL-7.